Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 162

1.

Expression of hypothalamic neurohormones and their receptors in the human eye.

Dubovy SR, Fernandez MP, Echegaray JJ, Block NL, Unoki N, Perez R, Vidaurre I, Lee RK, Nadji M, Schally AV.

Oncotarget. 2017 Jun 3. doi: 10.18632/oncotarget.18358. [Epub ahead of print]

2.

PD-L1 Expression in Carcinosarcomas of the Gynecologic Tract: A Potentially Actionable Biomarker.

Pinto A, Mackrides N, Nadji M.

Appl Immunohistochem Mol Morphol. 2016 Oct 31. [Epub ahead of print]

PMID:
27801734
3.

Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians.

Koru-Sengul T, Santander AM, Miao F, Sanchez LG, Jorda M, Glück S, Ince TA, Nadji M, Chen Z, Penichet ML, Cleary MP, Torroella-Kouri M.

Breast Cancer Res Treat. 2016 Jul;158(1):113-26. doi: 10.1007/s10549-016-3847-3. Epub 2016 Jun 9.

PMID:
27283835
4.

Colorectal Tumors From Different Racial and Ethnic Minorities Have Similar Rates of Mismatch Repair Deficiency.

Berera S, Koru-Sengul T, Miao F, Carrasquillo O, Nadji M, Zhang Y, Hosein PJ, McCauley JL, Abreu MT, Sussman DA.

Clin Gastroenterol Hepatol. 2016 Aug;14(8):1163-71. doi: 10.1016/j.cgh.2016.03.037. Epub 2016 Apr 1.

PMID:
27046481
5.

GHRH Receptor Expression in Malignant Mixed Müllerian Tumors: A Potentially Targetable Biopredictor.

Mackrides N, Ganjei-Azar P, Perez R, Cui T, Block N, Schally AV, Nadji M.

Int J Gynecol Pathol. 2016 Mar;35(2):142-6. doi: 10.1097/PGP.0000000000000229.

PMID:
26535981
6.

Acute presentation of brachial plexus schwannoma secondary to infarction.

Sidani C, Saraf-Lavi E, Lyapichev KA, Nadji M, Levi AD.

Neuroradiol J. 2015 Jun;28(3):333-6. doi: 10.1177/1971400915594923.

7.

The Immunophenotype of Nodular Variant of Medullary Carcinoma of the Breast.

Reyes C, Nadji M.

Appl Immunohistochem Mol Morphol. 2015 Oct;23(9):624-7. doi: 10.1097/PAI.0000000000000161.

PMID:
25710588
8.

Phospholipid makeup of the breast adipose tissue is impacted by obesity and mammary cancer in the mouse: Results of a pilot study.

Margolis M, Perez O Jr, Martinez M, Santander AM, Mendez AJ, Nadji M, Nayer A, Bhattacharya S, Torroella-Kouri M.

Biochimie. 2015 Jan;108:133-9. doi: 10.1016/j.biochi.2014.11.009. Epub 2014 Nov 18.

9.

Intra-observer reproducibility of whole slide imaging for the primary diagnosis of breast needle biopsies.

Reyes C, Ikpatt OF, Nadji M, Cote RJ.

J Pathol Inform. 2014 Feb 25;5(1):5. doi: 10.4103/2153-3539.127814. eCollection 2014.

10.

Brief formalin fixation and rapid tissue processing do not affect the sensitivity of ER immunohistochemistry of breast core biopsies.

Sujoy V, Nadji M, Morales AR.

Am J Clin Pathol. 2014 Apr;141(4):522-6. doi: 10.1309/AJCPO7Z4SFIYDSXN.

PMID:
24619753
11.

Evaluation of quality of life in complete locked-in syndrome patients.

Rousseau MC, Pietra S, Nadji M, Billette de Villemeur T.

J Palliat Med. 2013 Nov;16(11):1455-8. doi: 10.1089/jpm.2013.0120.

PMID:
24215251
12.

Tumor microenvironment profoundly modifies functional status of macrophages: peritoneal and tumor-associated macrophages are two very different subpopulations.

Rodríguez D, Silvera R, Carrio R, Nadji M, Caso R, Rodríguez G, Iragavarapu-Charyulu V, Torroella-Kouri M.

Cell Immunol. 2013 May-Jun;283(1-2):51-60. doi: 10.1016/j.cellimm.2013.06.008. Epub 2013 Jun 19.

13.

Powerful inhibition of experimental human pancreatic cancers by receptor targeted cytotoxic LH-RH analog AEZS-108.

Szepeshazi K, Schally AV, Block NL, Halmos G, Nadji M, Szalontay L, Vidaurre I, Abi-Chaker A, Rick FG.

Oncotarget. 2013 May;4(5):751-60.

14.

Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone.

Jaszberenyi M, Schally AV, Block NL, Nadji M, Vidaurre I, Szalontay L, Rick FG.

Oncotarget. 2013 Mar;4(3):422-32.

15.

Macrophages as independent prognostic factors in small T1 breast cancers.

Carrio R, Koru-Sengul T, Miao F, Glück S, Lopez O, Selman Y, Alvarez C, Milikowski C, Gomez C, Jorda M, Nadji M, Torroella-Kouri M.

Oncol Rep. 2013 Jan;29(1):141-8. doi: 10.3892/or.2012.2088. Epub 2012 Oct 17.

PMID:
23076599
16.

Metaplastic and medullary mammary carcinomas do not express mammaglobin.

Reyes C, Gomez-Fernández C, Nadji M.

Am J Clin Pathol. 2012 May;137(5):747-52. doi: 10.1309/AJCP5W5SEZSEHUHE.

PMID:
22523213
17.

Inhibitory effects of GHRH antagonists on human GH-secreting adenoma tissue.

Szalontay L, Benveniste RJ, Schally AV, Vidaurre I, Nadji M, Zarandi M, Block NL, Kovacs M.

Neuroendocrinology. 2012;96(1):81-8. doi: 10.1159/000335989. Epub 2012 Feb 29.

PMID:
22377963
18.

Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage.

Rick FG, Szalontay L, Schally AV, Block NL, Nadji M, Szepeshazi K, Vidaurre I, Zarandi M, Kovacs M, Rekasi Z.

J Urol. 2012 Apr;187(4):1498-504. doi: 10.1016/j.juro.2011.11.081. Epub 2012 Feb 17.

PMID:
22341819
19.

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.

Rick FG, Schally AV, Szalontay L, Block NL, Szepeshazi K, Nadji M, Zarandi M, Hohla F, Buchholz S, Seitz S.

Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1655-60. doi: 10.1073/pnas.1120588109. Epub 2012 Jan 18.

20.

Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy.

Shamsi Meymandi S, Javadi A, Dabiri S, Shamsi Meymandi M, Nadji M.

Arch Iran Med. 2011 Jul;14(4):238-43. doi: 0011144/AIM.003.

Supplemental Content

Support Center